Interleukin-1 binding and prostaglandin E2 synthesis by amnion cells in culture: regulation by tumor necrosis factor-α, transforming growth factor-β, and interleukin-1 receptor antagonist
- 24 March 1993
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1181 (1) , 31-36
- https://doi.org/10.1016/0925-4439(93)90086-g
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Localization of Transforming Growth Factor-β at the Human Fetal-Maternal Interface: Role in Trophoblast Growth and Differentiation1Biology of Reproduction, 1992
- Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.Journal of Clinical Investigation, 1991
- Induction of the interleukin 1 receptor antagonist protein by transforming growth factor‐βEuropean Journal of Immunology, 1991
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990
- Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.Journal of Clinical Investigation, 1990
- Characterization and hormonal modulation of il-1 binding in neonatal mouse osteoblastlike cellsJournal of Bone and Mineral Research, 1990
- Interleukin 1‐ and tumor necrosis factor‐stimulation of prostaglandin E2 synthesis in MDCK cells, and potentiation of this effect by cycloheximideFEBS Letters, 1990
- Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonistNature, 1990
- Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cellsBiochemical and Biophysical Research Communications, 1989
- Interleukin 1 stimulates its own receptor expression on human fibroblasts through the endogenous production of prostaglandin(s).Journal of Clinical Investigation, 1988